Sol-Gel Technologies Ltd.
SLGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684693
In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 8 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Sol-Gel Technologies Ltd. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 11 | 10 | −1 |
| Shares | 658.4K | 558.5K | −99.9K (−15.2%) |
| Value | $4.87M | $16.3M | +$11.4M (+234.1%) |
New holders (2)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 204,835 | $5.97M | 0.84% |
| Menora Mivtachim Holdings Ltd. | 7,611 | $221.9K | 0.00% |
Sold out (3)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Yelin Lapidot Holdings Management Ltd. | 17,753 | $131.4K |
| Raymond James Financial Inc | 10,486 | $77.6K |
| UBS Group AG | 7,337 | $54.3K |